Institute For Aging Research, Hebrew Senior Life, Boston, MA 02131, USA.
Exp Physiol. 2013 Feb;98(2):451-61. doi: 10.1113/expphysiol.2012.066118. Epub 2012 Sep 28.
We tested the hypothesis that pharmacological blockade of α(1)-adrenoreceptors (by prazosin), at rest and during steady-state dynamic exercise, would impair cerebral autoregulation and result in cerebral vasodilatation in healthy humans. In 10 subjects, beat-to-beat mean arterial pressure and mean middle cerebral artery blood velocity were determined at rest and during low (Ex90) and moderate workload (Ex130) on an upright bicycle ergometer without and with prazosin. Plasma noradrenaline concentrations increased significantly from rest to Ex130 during control conditions (from 1.8 ± 0.2 to 3.2 ± 0.3 pmol (ml plasma)(-1)). In the control conditions, the transfer function gain between mean arterial pressure and mean middle cerebral artery blood velocity in the low-frequency range was decreased at Ex90 (P = 0.035) and Ex130 (P = 0.027) from rest. A significant increase in critical closing pressure (CCP) was also observed in the control conditions from rest to Ex90 to Ex130 (from 18 ± 3 to 24 ± 4 to 31 ± 4 mmHg). An average of 74 ± 2% blockade of blood pressure response was achieved with oral prazosin. Following blockade, plasma noradrenaline concentrations further increased at rest and during Ex130 from the control value (from 2.6 ± 0.3 to 4.4 ± 0.5 pmol (ml plasma)(-1)). Prazosin also resulted in an increase in low-frequency gain (P < 0.003) compared with the control conditions. Prazosin blockade abolished the increases in CCP during Ex130 and increased the cerebrovascular conductance index (P = 0.018). These data indicate that in the control conditions a strengthening of cerebral autoregulation occurred with moderate dynamic exercise that is associated with an increase in CCP as a result of the exercise-mediated augmentation of sympathetic activity. Given that α(1)-adrenergic receptor blockade attenuated the increase in dynamic cerebral autoregulation and CCP, we conclude that increases in sympathetic activity have a role in establishing cerebral vascular tone in humans.
我们测试了一个假设,即药理学阻断α(1)-肾上腺素能受体(通过哌唑嗪),在休息和稳定状态下的动态运动时,会损害大脑自动调节并导致健康人的脑血管扩张。在 10 名受试者中,在直立自行车测力计上,在休息时和低(Ex90)和中(Ex130)工作负荷下,测定逐搏平均动脉压和平均大脑中动脉血流速度,而没有和有哌唑嗪。在对照条件下,去甲肾上腺素浓度从休息时到 Ex130 显著增加(从 1.8 ± 0.2 到 3.2 ± 0.3 pmol (ml 血浆)(-1))。在对照条件下,低频率范围内平均动脉压与平均大脑中动脉血流速度之间的传递函数增益在 Ex90(P = 0.035)和 Ex130(P = 0.027)时从休息时降低。在对照条件下,从休息到 Ex90 到 Ex130,临界关闭压力(CCP)也显著增加(从 18 ± 3 到 24 ± 4 到 31 ± 4 mmHg)。口服哌唑嗪平均实现 74 ± 2%的血压反应阻断。阻断后,去甲肾上腺素浓度在休息和 Ex130 时比对照值进一步增加(从 2.6 ± 0.3 到 4.4 ± 0.5 pmol (ml 血浆)(-1))。与对照条件相比,哌唑嗪还导致低频增益增加(P < 0.003)。哌唑嗪阻断消除了 Ex130 期间 CCP 的增加,并增加了脑血管导纳指数(P = 0.018)。这些数据表明,在对照条件下,中度动态运动时发生了大脑自动调节的增强,这与交感神经活动增强导致的 CCP 增加有关。由于α(1)-肾上腺素能受体阻断削弱了动态大脑自动调节和 CCP 的增加,我们得出结论,交感神经活动的增加在人类建立脑血管张力方面发挥了作用。